annual current assets:
$18.66B-$818.30M(-4.20%)Summary
- As of today (June 1, 2025), REGN annual total current assets is $18.66 billion, with the most recent change of -$818.30 million (-4.20%) on December 31, 2024.
- During the last 3 years, REGN annual current assets has risen by +$4.65 billion (+33.15%).
- REGN annual current assets is now -4.20% below its all-time high of $19.48 billion, reached on December 31, 2023.
Performance
REGN Current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current assets:
$17.57B-$1.09B(-5.84%)Summary
- As of today (June 1, 2025), REGN quarterly total current assets is $17.57 billion, with the most recent change of -$1.09 billion (-5.84%) on March 31, 2025.
- Over the past year, REGN quarterly current assets has dropped by -$1.30 billion (-6.89%).
- REGN quarterly current assets is now -9.79% below its all-time high of $19.48 billion, reached on December 31, 2023.
Performance
REGN quarterly current assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
REGN Current assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.2% | -6.9% |
| 3 y3 years | +33.1% | +22.8% |
| 5 y5 years | +142.7% | +103.3% |
REGN Current assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +33.1% | -9.8% | +22.8% |
| 5 y | 5-year | -4.2% | +142.7% | -9.8% | +123.5% |
| alltime | all time | -4.2% | >+9999.0% | -9.8% | >+9999.0% |
REGN Current assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $17.57B(-5.8%) |
| Dec 2024 | $19.10B(+40.4%) | $18.66B(-3.5%) |
| Sep 2024 | - | $19.33B(+1.3%) |
| Jun 2024 | - | $19.08B(+1.1%) |
| Mar 2024 | - | $18.87B(-3.1%) |
| Dec 2023 | $13.60B(+2.0%) | $19.48B(+4.5%) |
| Sep 2023 | - | $18.63B(+10.1%) |
| Jun 2023 | - | $16.92B(+0.1%) |
| Mar 2023 | - | $16.91B(+6.5%) |
| Dec 2022 | $13.33B(+16.7%) | $15.88B(+3.0%) |
| Sep 2022 | - | $15.43B(-0.7%) |
| Jun 2022 | - | $15.53B(+8.6%) |
| Mar 2022 | - | $14.31B(+2.1%) |
| Dec 2021 | $11.42B(+54.7%) | $14.01B(+1.7%) |
| Sep 2021 | - | $13.78B(+3.3%) |
| Jun 2021 | - | $13.34B(+32.6%) |
| Mar 2021 | - | $10.06B(+2.8%) |
| Dec 2020 | $7.38B(+3.8%) | $9.78B(+7.5%) |
| Sep 2020 | - | $9.10B(+15.7%) |
| Jun 2020 | - | $7.86B(-9.1%) |
| Mar 2020 | - | $8.64B(+12.4%) |
| Dec 2019 | $7.12B(+34.6%) | $7.69B(+8.2%) |
| Sep 2019 | - | $7.11B(+6.9%) |
| Jun 2019 | - | $6.65B(-4.0%) |
| Mar 2019 | - | $6.93B(+7.5%) |
| Dec 2018 | $5.29B(+19.4%) | $6.45B(+12.7%) |
| Sep 2018 | - | $5.72B(+18.8%) |
| Jun 2018 | - | $4.81B(+5.9%) |
| Mar 2018 | - | $4.54B(+4.8%) |
| Dec 2017 | $4.43B(+16.8%) | $4.33B(+4.8%) |
| Sep 2017 | - | $4.14B(+7.1%) |
| Jun 2017 | - | $3.86B(+5.2%) |
| Mar 2017 | - | $3.67B(+15.4%) |
| Dec 2016 | $3.79B(+40.8%) | $3.18B(-9.2%) |
| Sep 2016 | - | $3.50B(+9.1%) |
| Jun 2016 | - | $3.21B(+2.4%) |
| Mar 2016 | - | $3.13B(+7.5%) |
| Dec 2015 | $2.69B(+53.7%) | $2.92B(+8.9%) |
| Sep 2015 | - | $2.68B(+17.2%) |
| Jun 2015 | - | $2.28B(-1.2%) |
| Mar 2015 | - | $2.31B(+10.8%) |
| Dec 2014 | $1.75B(+51.9%) | $2.08B(-5.3%) |
| Sep 2014 | - | $2.20B(+14.7%) |
| Jun 2014 | - | $1.92B(+2.5%) |
| Mar 2014 | - | $1.87B(+4.1%) |
| Dec 2013 | $1.15B(+32.0%) | $1.80B(+10.0%) |
| Sep 2013 | - | $1.63B(+4.7%) |
| Jun 2013 | - | $1.56B(+19.5%) |
| Mar 2013 | - | $1.31B(+8.4%) |
| Dec 2012 | $874.48M(+32.9%) | $1.21B(+27.1%) |
| Sep 2012 | - | $948.60M(+23.3%) |
| Jun 2012 | - | $769.19M(+10.4%) |
| Mar 2012 | - | $696.91M(+4.7%) |
| Dec 2011 | $657.81M(-10.1%) | $665.78M(+95.9%) |
| Sep 2011 | - | $339.87M(-17.8%) |
| Jun 2011 | - | $413.27M(+27.0%) |
| Mar 2011 | - | $325.50M(-9.0%) |
| Dec 2010 | $731.81M(+131.8%) | $357.62M(-37.9%) |
| Sep 2010 | - | $575.72M(+37.8%) |
| Jun 2010 | - | $417.75M(+5.6%) |
| Mar 2010 | - | $395.44M(-7.1%) |
| Dec 2009 | $315.69M(+55.7%) | $425.51M(-7.8%) |
| Sep 2009 | - | $461.59M(-0.7%) |
| Jun 2009 | - | $465.03M(-3.9%) |
| Mar 2009 | - | $483.79M(-7.2%) |
| Dec 2008 | $202.78M | $521.44M(-27.1%) |
| Sep 2008 | - | $715.54M(-3.6%) |
| Jun 2008 | - | $742.39M(-5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2008 | - | $787.50M(-1.3%) |
| Dec 2007 | $138.43M(+20.3%) | $797.83M(+89.1%) |
| Sep 2007 | - | $422.02M(-15.1%) |
| Jun 2007 | - | $496.98M(+1.6%) |
| Mar 2007 | - | $489.16M(+4.1%) |
| Dec 2006 | $115.11M(+40.2%) | $469.98M(+71.7%) |
| Sep 2006 | - | $273.75M(-5.9%) |
| Jun 2006 | - | $291.06M(-8.9%) |
| Mar 2006 | - | $319.65M(-6.4%) |
| Dec 2005 | $82.11M(-36.4%) | $341.39M(+5.1%) |
| Sep 2005 | - | $324.96M(-9.6%) |
| Jun 2005 | - | $359.31M(-2.9%) |
| Mar 2005 | - | $369.85M(+7.5%) |
| Dec 2004 | $129.15M(-18.9%) | $343.95M(+10.5%) |
| Sep 2004 | - | $311.24M(-18.8%) |
| Jun 2004 | - | $383.33M(-2.3%) |
| Mar 2004 | - | $392.28M(+22.5%) |
| Dec 2003 | $159.35M(+39.0%) | $320.21M(-20.8%) |
| Sep 2003 | - | $404.38M(+37.0%) |
| Jun 2003 | - | $295.15M(-10.5%) |
| Mar 2003 | - | $329.74M(+19.1%) |
| Dec 2002 | $114.63M(+13.3%) | $276.95M(-11.8%) |
| Sep 2002 | - | $313.82M(+1.3%) |
| Jun 2002 | - | $309.70M(-8.1%) |
| Mar 2002 | - | $337.12M(-14.5%) |
| Dec 2001 | $101.21M(+36.5%) | $394.19M(+56.0%) |
| Sep 2001 | - | $252.73M(-0.0%) |
| Jun 2001 | - | $252.78M(-11.8%) |
| Mar 2001 | - | $286.64M(+113.7%) |
| Dec 2000 | $74.13M(+15.8%) | $134.14M(-2.1%) |
| Sep 2000 | - | $137.00M(-0.3%) |
| Jun 2000 | - | $137.46M(+87.1%) |
| Mar 2000 | - | $73.48M(+0.7%) |
| Dec 1999 | $64.00M(0.0%) | $73.00M(-1.6%) |
| Sep 1999 | - | $74.20M(-2.6%) |
| Jun 1999 | - | $76.20M(0.0%) |
| Mar 1999 | - | $76.20M(-18.0%) |
| Dec 1998 | $64.00M(-7.0%) | $92.90M(+4.1%) |
| Sep 1998 | - | $89.20M(+0.9%) |
| Jun 1998 | - | $88.40M(-2.8%) |
| Mar 1998 | - | $90.90M(-8.7%) |
| Dec 1997 | $68.80M(+30.8%) | $99.60M(-2.4%) |
| Sep 1997 | - | $102.10M(-7.7%) |
| Jun 1997 | - | $110.60M(+53.8%) |
| Mar 1997 | - | $71.90M(-15.4%) |
| Dec 1996 | $52.60M(+17.9%) | $85.00M(+15.8%) |
| Sep 1996 | - | $73.40M(-10.2%) |
| Jun 1996 | - | $81.70M(+112.2%) |
| Mar 1996 | - | $38.50M(-21.7%) |
| Dec 1995 | $44.60M(+5.7%) | $49.20M(+60.8%) |
| Sep 1995 | - | $30.60M(-22.5%) |
| Jun 1995 | - | $39.50M(+4.2%) |
| Mar 1995 | - | $37.90M(-27.1%) |
| Dec 1994 | $42.20M(+63.6%) | $52.00M(+10.6%) |
| Sep 1994 | - | $47.00M(-15.0%) |
| Jun 1994 | - | $55.30M(+24.0%) |
| Mar 1994 | - | $44.60M(-51.4%) |
| Dec 1993 | $25.80M(+95.5%) | $91.80M(-16.2%) |
| Sep 1993 | - | $109.60M(+61.9%) |
| Jun 1993 | - | $67.70M(-11.8%) |
| Mar 1993 | - | $76.80M(-9.3%) |
| Dec 1992 | $13.20M(+78.4%) | $84.70M(-7.8%) |
| Sep 1992 | - | $91.90M(-5.6%) |
| Jun 1992 | - | $97.40M(-4.9%) |
| Mar 1992 | - | $102.40M(-3.9%) |
| Dec 1991 | $7.40M(+146.7%) | $106.60M(-2.7%) |
| Sep 1991 | - | $109.60M(-1.5%) |
| Jun 1991 | - | $111.30M(+396.9%) |
| Dec 1990 | $3.00M | $22.40M |
FAQ
- What is Regeneron Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual current assets year-on-year change?
- What is Regeneron Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly current assets year-on-year change?
What is Regeneron Pharmaceuticals annual total current assets?
The current annual current assets of REGN is $18.66B
What is the all time high annual current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual total current assets is $19.48B
What is Regeneron Pharmaceuticals annual current assets year-on-year change?
Over the past year, REGN annual total current assets has changed by -$818.30M (-4.20%)
What is Regeneron Pharmaceuticals quarterly total current assets?
The current quarterly current assets of REGN is $17.57B
What is the all time high quarterly current assets for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly total current assets is $19.48B
What is Regeneron Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, REGN quarterly total current assets has changed by -$1.30B (-6.89%)